SCHEMBL20101027

SCHEMBL20101027

CC(C)/C(=N\Nc1nc2cc(C(F)(F)F)ccc2s1)c1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.48
HSP90AA1 P07900 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
HIF1A Q16665 1/20 0.47
NCS1 P62166 1/20 0.45
MAPT P10636 3/20 0.39
NPC1 O15118 2/20 0.39
OPRK1 P41145 2/20 0.39
HTT P42858 2/20 0.39
RAB9A P51151 2/20 0.39
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
POLB P06746 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
PKM P14618 1/20 0.39
AGTR1 P30556 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PIK3CG P48736 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20101035 0.87 HSP90AA1 (0.54) DYRK1AHSP90AA1ALDH1A1CYP1A2CYP3A4
SCHEMBL17985744 0.84 ALDH1A1 (0.65) DYRK1AHSP90AA1ALDH1A1CYP1A2CYP3A4
SCHEMBL20101038 0.83 HSP90AA1 (0.71) DYRK1AHSP90AA1ALDH1A1CYP1A2CYP3A4
SCHEMBL17963013 0.72 HSP90AA1 (0.57) DYRK1AHSP90AA1ALDH1A1CYP1A2CYP3A4
SCHEMBL17985747 0.69 HSP90AA1 (0.76) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL17987878 0.69 HSP90AA1 (0.55) DYRK1AHSP90AA1ALDH1A1CYP1A2CYP3A4
SCHEMBL20101082 0.68 HSP90AA1 (0.85) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL17987886 0.68 HSP90AA1 (0.54) DYRK1AHSP90AA1ALDH1A1CYP1A2CYP3A4
SCHEMBL20101036 0.67 HSP90AA1 (0.76) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL17963015 0.66 HSP90AA1 (0.65) DYRK1AHSP90AA1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081612-A1 COMPOUNDS AND METHODS FOR TREATING CANCER ACTAVALON, INC. (US) 2018-05-03 WO disclosed